In honor of the 50th anniversary of the National Cancer Act, Dr. Norman Sharpless, director of the National Cancer Institute, and Dr. Henry Ciolino, director of the Office of NCI Cancer Centers, join Dr. Roy Jensen, vice chancellor and director of The University of Kansas Cancer Center, on a very special episode to discuss all things cancer research.

Study results show CAR T-cell therapy improves survival for adults with large B-cell lymphoma who did not respond well to or relapsed after, the first line of treatment. Learn about CAR T-cell therapy for large B-cell lymphoma from Dr. Joseph McGuirk, medical director of the blood and marrow transplant program at The University of Kansas Cancer Center.

18 months into a global pandemic, half of the United States has been vaccinated against COVID-19, but we are at the height of yet another surge as the highly contagious Delta variant rages. Dr. Wejing Sun, director of Medical Oncology and associate director for clinical research at The University of Kansas Cancer Center, explains how we care for one of our most vulnerable populations, our cancer patients, who are uniquely susceptible to this deadly infectious disease.

Dr. Roy Jensen, director of The University of Kansas Cancer Center, talks with Annie Seal, children's program director at Turning Point, and Laura Frees, co-survivor and member of Patient and Investigator Voices Organizing Together (PIVOT), on how to talk to children about a loved one's cancer diagnosis.

Experts discuss the progress we are making toward being able to provide proton therapy for our patients. Proton therapy is the most technologically advanced method to deliver radiation treatment to cancerous tumors available today.